This study evaluates the chemical composition and bioactivities of essential oils extracted from the leaves and twigs of Glycosmis lanceolata growing in a natural forest in Vietnam. gas chromatography–mass spectrometry identified 42 and 43 constituents in the leaf and twig oils, respectively. The main compounds in the leaf oil were (E)-β-caryophyllene (10.2%), β-bisabolene (23.7%), and brevifolin (21.3%), while the twig oil was dominated by β-bisabolene (11.6%) and brevifolin (12.7%). Neither oil exhibited inhibitory effects against two beneficial bacterial strains, Bacillus subtilis and Lactobacillus fermentum. In contrast, both oils showed weak antimicrobial activity against four pathogenic bacteria—Staphylococcus aureus, Salmonella enterica, Escherichia coli, and Pseudomonas aeruginosa—and one yeast, Candida albicans, with IC50 values ranging from 2012 ± 118 to 10,593 ± 557 µg/mL. Notably, the twig oil demonstrated pronounced anti-inflammatory activity via inhibition of nitric oxide production (IC50 = 29.7 ± 2.58 µg/mL), whereas the leaf oil showed no detectable activity within the tested concentrations. Similarly, DPPH radical scavenging assays indicated stronger antioxidant activity for the twig oil compared to the leaf oil. These findings provide new insights into the phytochemistry and bioactivities of G. lanceolata essential oils and may support further investigations into their potential applications.
Le et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: